Ultragenyx Pharmaceutical Inc. (RARE) Capital expenditures 2016–2025
Ultragenyx Pharmaceutical Inc. (RARE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$6.0MFY2025 · since FY2016: $10.2M → $6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.0M | -14.3% |
| FY2024 | $7.0M | -84.1% |
| FY2023 | $44.0M | -62.1% |
| FY2022 | $116.1M | +58.9% |
| FY2021 | $73.1M | +66.5% |
| FY2020 | $43.9M | +76.8% |
| FY2019 | $24.8M | +509.2% |
| FY2018 | $4.1M | +45.9% |
| FY2017 | $2.8M | -72.6% |
| FY2016 | $10.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice